To date, no study has been conducted to assess whether PARP1 rs1136410 and rs8679 SNPs, two potentially functional sites, are useful biomarkers to predict the survival of esophageal squamous cell carcinoma (ESCC) patients in Cixian high-incidence region. The gene discussed is PARP1; the disease is esophageal squamous cell carcinoma.